drugset / Trial / NCT00236106

Short Term Growth in Children With Atopic Dermatitis

NCT00236106

Phase 4 Completed 20 enrolled Children´s Clinic, Randers
RandomizedCrossoverSingle-blind

Summary

Main objective:to assess short term growth in children with atopic dermatitis during treatment with tacrolimus 0.1% and mometasone furoate 0.1%. A singl blind randomised cross over trial including 20 children. The study consists of 5 periods: run in, treatment(1),wash out, treatment(2) and run out. Each period 14 days where the children will use tacrolimus ointment tvice daily, mometasone furoate once daily or moisturizer (in run in wash out and run out)

Timeline

Start
2005-02
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 0.1 %
Subject Tacrolimus Small molecule 0.1 % Topical

Indications